|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 307K 283K 263K 497K 33.26M 507K 3.4M 1.32M 16.32M 1.31M 1.28M 56.81M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.22M 1.12M 1.04M 1.97M 132M 2.01M 13.47M 5.22M 64.66M 5.2M 5.09M 225M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 01/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% | |||
| 04-14 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 283K 261K 243K 458K 30.67M 468K 3.14M 1.22M 15.06M 1.21M 1.19M 52.4M | 350K 308K 283K 264K 498K 33.31M 508K 3.41M 1.32M 16.35M 1.32M 1.29M 56.91M |
| Net income | -685K -602K -554K -516K -973K -65.15M -993K -6.66M -2.58M -31.98M -2.57M -2.52M -111M | -9.09M -7.98M -7.35M -6.85M -12.91M -864M -13.17M -88.36M -34.23M -424M -34.13M -33.39M -1.48B |
| Net Debt | 1.27M 1.12M 1.03M 959K 1.81M 121M 1.85M 12.38M 4.8M 59.44M 4.78M 4.68M 207M | 1.04M 909K 837K 780K 1.47M 98.46M 1.5M 10.07M 3.9M 48.33M 3.89M 3.8M 168M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















